Bipolar disorder and aggression

International Journal of Clinical Practice

Volumn 63, Issue 6, 2009, Pages 889-899

  Latalova K ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CLONIDINE; HALOPERIDOL; LITHIUM; LORAZEPAM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE;

AGGRESSION; AGITATION; AKATHISIA; BIPOLAR DISORDER; BIPOLAR I DISORDER; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED CLINICAL TRIAL; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; HOSPITAL PATIENT; HUMAN; LOW DRUG DOSE; MANIA; MEDLINE; METABOLIC DISORDER; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCINFO; REVIEW; SEDATION; SIDE EFFECT; SUBSTANCE ABUSE; WEIGHT GAIN; CROSS-SECTIONAL STUDY; DRUG ADMINISTRATION ROUTE; IMPULSIVENESS; PREVALENCE; PSYCHOLOGY; PSYCHOMOTOR AGITATION;

AGGRESSION; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; DRUG ADMINISTRATION ROUTES; HUMANS; IMPULSIVE BEHAVIOR; PREVALENCE; PSYCHOMOTOR AGITATION;

EID: 65649090551     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2009.02001.x     Document Type: Review

References (87)

1. Cassidy F, Forest K, Murry E, Carroll BJ. A factor analysis of the signs and symptoms of mania. Arch Gen Psychiatry 1998 55 : 27 32.
2. Sato T, Bottlender R, Kleindienst N, Moller HJ. Syndromes and phenomenological subtypes underlying acute mania: a factor analytic study of 576 manic patients. Am J Psychiatry 2002 159 : 968 74.
3. Torrey EF. Stigma and violence. Psychiatr Serv 2002 53 : 1179.
4. Moyer KE. The Psychobiology of Aggression. New York : Harper & Row, Publishers, 1976.
5. Silver JM, Yudofsky SC. The Overt Aggression Scale: overview and guiding principles. J Neuropsychiatry Clin Neurosci 1991 3 : S22 9.
6. Yudofsky SC, Silver JM, Jackson W, Endicott J, Williams D. The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry 1986 143 : 35 9.
7. Kay SR, Opler LA, Lindenmayer JP. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation. Br J Psychiatry 1989 155 (Suppl. 59 65.
8. Citrome L, Volavka J. Treatment of violent behavior. In : Tasman A, Kay J, Lieberman JA, eds. Psychiatry, 2nd edn. Chichester : John Wiley & Sons, Ltd, 2003 : 2136 46.
9. Binder RL, McNiel DE. Effects of diagnosis and context on dangerousness. Am J Psychiatry 1988 145 : 728 32.
10. Barlow K, Grenyer B, Ilkiw-Lavalle O. Prevalence and precipitants of aggression in psychiatric inpatient units. Aust N Z J Psychiatry 2000 34 : 967 74.
11. Corrigan PW, Watson AC. Findings from the National Comorbidity Survey on the frequency of violent behavior in individuals with psychiatric disorders. Psychiatry Res 2005 15 : 136.
12. Pulay AJ, Dawson DA, Hasin DS et al. Violent behavior and DSM-IV psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2007 12 : e1 11.
13. Grant BF, Stinson FS, Hasin DS et al. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2005 66 : 1205 15.
14. Cassidy F, Ahearn EP, Carroll BJ. Symptom profile consistency in recurrent manic episodes. Compr Psychiatry 2002 43 : 179 81.
15. Cassidy F, Murry E, Forest K, Carroll BJ. Signs and symptoms of mania in pure and mixed episodes. J Affect Disord 1998 50 : 187 201.
16. Oquendo MA, Waternaux C, Brodsky B et al. Suicidal behavior in bipolar mood disorder: clinical characteristics of attempters and nonattempters. J Affect Disord 2000 59 : 107 17.
17. Michaelis BH, Goldberg JF, Davis GP, Singer TM, Garno JL, Wenze SJ. Dimensions of impulsivity and aggression associated with suicide attempts among bipolar patients: a preliminary study. Suicide Life Threat Behav 2004 34 : 172 6.
18. Buss AH, Durkee A. An inventory for assessing different kinds of hostility. J Consult Psychol 1957 21 : 343 9.
19. Perlis RH, Miyahara S, Marangell LB et al. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Biol Psychiatry 2004 55 : 875 81.
20. Baldassano CF. Illness course, comorbidity, gender, and suicidality in patients with bipolar disorder. J Clin Psychiatry 2006 67 (Suppl. 11 8 11.
21. Salloum IM, Cornelius JR, Mezzich JE, Kirisci L. Impact of concurrent alcohol misuse on symptom presentation of acute mania at initial evaluation. Bipolar Disord 2002 4 : 418 21.
22. Swartz MS, Swanson JW, Hiday VA, Borum R, Wagner HR, Burns BJ. Violence and severe mental illness: the effects of substance abuse and nonadherence to medication. Am J Psychiatry 1998 155 : 226 31.
23. Thorneloe WF, Crews EL. Manic depressive illness concomitant with antisocial personality disorder: six case reports and review of the literature. J Clin Psychiatry 1981 42 : 5 9.
24. Good MI. Primary affective disorder, aggression, and criminality. A review and clinical study. Arch Gen Psychiatry 1978 35 : 954 60.
25. Garno JL, Gunawardane N, Goldberg JF. Predictors of trait aggression in bipolar disorder. Bipolar Disord 2008 10 : 285 92.
26. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res 1979 1 : 131 9.
27. Volavka J, Citrome L. Heterogeneity of violence in schizophrenia and implications for long-term treatment. Int J Clin Pract 2008 62 : 1237 45.
28. Swann AC, Anderson JC, Dougherty DM, Moeller FG. Measurement of inter-episode impulsivity in bipolar disorder. Psychiatry Res 2001 101 : 195 7.
29. Najt P, Perez J, Sanches M, Peluso MA, Glahn D, Soares JC. Impulsivity and bipolar disorder. Eur Neuropsychopharmacol 2007 17 : 313 20.
30. Siever LJ. Neurobiology of aggression and violence. Am J Psychiatry 2008 165 : 429 42.
31. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK. Low cerebrospinal fluid 5-hydroxyindole acetic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sci 1983 33 : 2609 14.
32. Coccaro EF, Siever LJ, Klar HM et al. Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatry 1989 46 : 587 99.
33. Frankle WG, Lombardo I, New AS et al. Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Psychiatry 2005 162 : 915 23.
34. Caspi A, McClay J, Moffitt TE et al. Role of genotype in the cycle of violence in maltreated children. Science 2002 297 : 851 4.
35. Oquendo MA, Mann JJ. The biology of impulsivity and suicidality. Psychiatr Clin North Am 2000 23 : 11 25.
36. Mur M, Portella MJ, Martinez-Aran A, Pifarre J, Vieta E. Persistent neuropsychological deficit in euthymic bipolar patients: executive function as a core deficit. J Clin Psychiatry 2007 68 : 1078 86.
37. Serper M, Beech DR, Harvey PD, Dill C. Neuropsychological and symptom predictors of aggression on the psychiatric inpatient service. J Clin Exp Neuropsychol 2008 30 : 700 9.
38. Krakowski MI, Czobor P. Clinical symptoms, neurological impairment, and prediction of violence in psychiatric inpatients. Hosp Community Psychiatry 1994 45 : 700 5.
39. Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry 1999 156 : 181 9.
40. Mohr P, Pecenak J, Svestka J, Swingler D, Treuer T. Treatment of acute agitation in psychotic disorders. Neuro Endocrinol Lett 2005 26 : 327 35.
41. Swann AC. Treatment of aggression in patients with bipolar disorder. J Clin Psychiatry Monogr 1999 17 : 18 21.
42. Villari V, Rocca P, Fonzo V, Montemagni C, Pandullo P, Bogetto F. Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation. Prog Neuropsychopharmacol Biol Psychiatry 2008 15 : 32.
43. Baker RW, Kinon BJ, Maguire GA, Liu H, Hill AL. Effectiveness of rapid initial dose escalation of up to forty milligrams per day of oral olanzapine in acute agitation. J Clin Psychopharmacol 2003 23 : 342 8.
44. Currier GW, Simpson GM. Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. J Clin Psychiatry 2001 62 : 153 7.
45. Meehan K, Zhang F, David S et al. A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol 2001 21 : 389 97.
46. San L, Arranz B, Querejeta I, Barrio S, De la GJ, Perez V. A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patients. Eur Psychiatry 2006 21 : 539 43.
47. Battaglia J, Lindborg SR, Alaka K, Meehan K, Wright P. Calming versus sedative effects of intramuscular olanzapine in agitated patients. Am J Emerg Med 2003 21 : 192 8.
48. Zimbroff DL, Marcus RN, Manos G et al. Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole. J Clin Psychopharmacol 2007 27 : 171 6.
49. Brook S, Walden J, Benattia I, Siu CO, Romano SJ. Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study. Psychopharmacology (Berl) 2005 178 : 514 23.
50. Citrome L. Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. J Clin Psychiatry 2007 68 : 1876 85.
51. Cochran SD. Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders. J Consult Clin Psychol 1984 52 : 873 8.
52. Basco MR, Rush AJ. Cognitive-Behavioral Therapy for Bipolar Disorder, 2nd edn. New York : Guilford, 2007.
53. Weiss RD, Griffin ML, Kolodziej ME et al. A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. Am J Psychiatry 2007 164 : 100 7.
54. Linehan MM. Dialectical behavior therapy for borderline personality disorder. Theory and method. Bull Menninger Clin 1987 51 : 261 76.
55. Linehan MM. Dialectical behavior therapy for treatment of borderline personality disorder: implications for the treatment of substance abuse. NIDA Res Monogr 1993 137 : 201 16.
56. Linehan MM. Combining pharmacotherapy with psychotherapy for substance abusers with borderline personality disorder: strategies for enhancing compliance. NIDA Res Monogr 1995 150 : 129 42.
57. Herman E, Grof P, Hovorka J, Praško J, Doubek P. Bipolar disorder [in Czech]. In : Seifertová D, Praško J, Höschl C, eds. Postupy v Léčbě Psychických Poruch. Prague : Academia Medica Pragensis, 2004 : 93 120.
58. Swann AC, Janicak PL, Calabrese JR et al. Structure of mania: depressive, irritable, and psychotic clusters with different retrospectively-assessed course patterns of illness in randomized clinical trial participants. J Affect Disord 2001 67 : 123 32.
59. Lindenmayer J-P, Kotsaftis A. Use of sodium valproate in violent and aggressive behaviors: a critical review. J Clin Psychiatry 2000 61 : 123 8.
60. Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD. Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania. Neuropsychopharmacology 2002 26 : 530 6.
61. Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP. The Expert Consensus Guideline Series: medication treatment of bipolar disorder. Postgrad Med 2000, Spec. No.: 1-104.
62. Yatham LN, Kennedy SH, O'Donovan C et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord 2005 7 (Suppl. 3 5 69.
63. Suppes T, Dennehy EB, Hirschfeld RM et al. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry 2005 66 : 870 86.
64. Hirschfeld RM, Keck PE Jr., Kramer M et al. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Am J Psychiatry 2004 161 : 1057 65.
65. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978 133 : 429 35.
66. Khanna S, Vieta E, Lyons B, Grossman F, Eerdekens M, Kramer M. Risperidone in the treatment of acute mania: double-blind, placebo-controlled study. Br J Psychiatry 2005 187 : 229 34.
67. Niufan G, Tohen M, Qiuqing A et al. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial. J Affect Disord 2008 105 : 101 8.
68. Vieta E, Panicali F, Goetz I, Reed C, Comes M, Tohen M. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study. J Affect Disord 2008 106 : 63 72.
69. Tohen M, Bowden CL, Smulevich AB et al. Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes. Br J Psychiatry 2008 192 : 135 43.
70. Citrome L, Krakowski M, Greenberg WM, Andrade E, Volavka J. Antiaggressive effect of quetiapine in a patient with schizoaffective disorder. J Clin Psychiatry 2001 62 : 901.
71. Sokolski KN, Denson TF. Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate. Prog Neuropsychopharmacol Biol Psychiatry 2003 27 : 863 6.
72. Buckley PF, Paulsson B, Brecher M. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine. J Affect Disord 2007 100 (Suppl. 1 S33 43.
73. Nasrallah HA, Brecher M, Paulsson B. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania. Bipolar Disord 2006 1 : 467 74.
74. Keck PE Jr., Marcus R, Tourkodimitris S et al. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 2003 160 : 1651 8.
75. Sachs G, Sanchez R, Marcus R et al. Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study. J Psychopharmacol 2006 20 : 536 46.
76. Frye MA, Eudicone J, Pikalov A, McQuade RD, Marcus RN, Carlson BX. Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: Young Mania Rating Scale line analysis from two, randomized, double-blind, placebo-controlled trials. J Clin Psychopharmacol 2008 28 : 243 5.
77. Keck PE Jr., Versiani M, Potkin S, West SA, Giller E, Ice K. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry 2003 160 : 741 8.
78. Potkin SG, Keck PE Jr., Segal S, Ice K, English P. Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial. J Clin Psychopharmacol 2005 25 : 301 10.
79. Cipriani A, Rendell JM, Geddes JR. Haloperidol alone or in combination for acute mania. Cochrane Database Syst Rev 2006 3 : CD004362.
80. Scherk H, Pajonk FG, Leucht S. Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Arch Gen Psychiatry 2007 64 : 442 55.
81. Smith LA, Cornelius V, Warnock A, Tacchi MJ, Taylor D. Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy. Acta Psychiatr Scand 2007 115 : 12 20.
82. Hassan M, Madhavan SS, Kalsekar ID et al. Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder. Ann Pharmacother 2007 41 : 1812 8.
83. Maguire J, Singh AN. Clonidine. An effective anti-manic agent? Br J Psychiatry 1987 150 : 863 4.
84. Hardy MC, Lecrubier Y, Widlocher D. Efficacy of clonidine in 24 patients with acute mania. Am J Psychiatry 1986 143 : 1450 3.
85. Hardy-Bayle MC, Lecrubier Y, Lancrenon S, Laine J, Allilaire JF, Des LA. Clonidine versus a placebo trial in manic disorder. Encephale 1989 15 : 523 6.
86. Janicak PG, Sharma RP, Easton M, Comaty JE, Davis JM. A double-blind, placebo-controlled trial of clonidine in the treatment of acute mania. Psychopharmacol Bull 1989 25 : 243 5.
87. Giannini AJ, Pascarzi GA, Loiselle RH, Price WA, Giannini MC. Comparison of clonidine and lithium in the treatment of mania. Am J Psychiatry 1986 143 : 1608 9.